Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? Cover

Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Radiology and Oncology

Volume 56 (2022): Issue 2 (June 2022)

By:

Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska and Julian Malicki

Open Access

|Mar 2022

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2022-0010 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 259 - 266

Submitted on: Oct 21, 2021

Accepted on: Jan 31, 2022

Published on: Mar 28, 2022

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

prostate carcinoma,

stereotactic radiotherapy,

intensity-modulated radiotherapy,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 2 (June 2022)